Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Colorcon
Baxter
McKinsey
Express Scripts
AstraZeneca
Johnson and Johnson

Last Updated: November 13, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Antipyrine

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Antipyrine?

Antipyrine is an investigational drug.

There have been 5 clinical trials for Antipyrine. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Dysmenorrhea, Turner Syndrome, and Syndrome. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Global United Pharmaceutical Corporation, and Pernix Theraputics LLC.

There are seven hundred and eighty-five US patents protecting this investigational drug and nine international patents.

Recent Clinical Trials for Antipyrine
TitleSponsorPhase
Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic AdultsGlobal United Pharmaceutical CorporationPhase 2
Four Arm Safety & Efficacy With Antipyrine and Benzocaine Otic Solution in Children With Acute Otitis MediaPernix Theraputics LLCPhase 2
Study to Assess the Safety and Efficacy of Etoricoxib Versus Ibuprofen in the Treatment of Dysmenorrhea (MK-0663-145 AM1)Merck Sharp & Dohme Corp.Phase 3

See all Antipyrine clinical trials

Clinical Trial Summary for Antipyrine

Top disease conditions for Antipyrine
Top clinical trial sponsors for Antipyrine

See all Antipyrine clinical trials

US Patents for Antipyrine

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Antipyrine   Start Trial Heterocyclic compound Takeda Pharmaceutical Company Limited (Osaka, JP)   Start Trial
Antipyrine   Start Trial Small molecules for the modulation of MCL-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders Dana-Farber Cancer Institute, Inc. (Boston, MA)   Start Trial
Antipyrine   Start Trial Monomethylvaline compounds having phenylalanine side-chain modification at the C-terminus Seattle Genetics, Inc. (Bothell, WA)   Start Trial
Antipyrine   Start Trial In vitro test system to evaluate xenobiotics as immune-modulators of drug transport and metabolism in human hepatocytes XENOTECH LLC (Lenexa, KS)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Antipyrine

Drugname Country Document Number Estimated Expiration Related US Patent
Antipyrine Canada 2961033 2034-09-11   Start Trial
Antipyrine European Patent Office 3192791 2034-09-11   Start Trial
Antipyrine Japan WO2016039408 2034-09-11   Start Trial
Antipyrine World Intellectual Property Organization (WIPO) 2016039408 2034-09-11   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Baxter
AstraZeneca
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.